London, England, United Kingdom · Hybrid
We are seeking a Protective Security Analyst to support the delivery of protective security and protective intelligence services across a portfolio of UHNW and private client projects. Based from Prevail’s London office,…
Skills: Intelligence Analysis, OSINT, Threat Assessment, Protective Security, Risk Management
London, England, United Kingdom • Hybrid
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Monitor open source and social media to identify threats and assess online exposure for UHNW and private clients. Produce practical intelligence products and support the operational planning of security for residences, movements, and events.
Requires professional experience in intelligence or security analysis with a proven ability to produce high-quality threat assessments and OSINT reports. Must possess strong analytical skills, discretion, and the legal right to work in the UK.
We are seeking a Protective Security Analyst to support the delivery of protective security and protective intelligence services across a portfolio of UHNW and private client projects.
Based from Prevail’s London office, the role will support CPOs, Security Advisors, site teams and Prevail leadership by monitoring threats, assessing online exposure, producing practical security reporting and helping ensure protective security delivery is informed, discreet and responsive.
The role will involve open source research, media and social media monitoring, incident reporting, protective intelligence analysis, briefing production and operational coordination support. It may also involve occasional travel to client residences, operational sites and stakeholder meetings across the UK.
The successful candidate will need strong analytical judgement, discretion, attention to detail and the ability to turn information into clear operational insight for protective security teams.
Key Responsibilities
Essential Requirements
Desirable
What We Are Looking For
We are looking for a calm, discreet and detail focused analyst who can support protective security delivery across multiple sensitive client projects.
The right person will understand that intelligence in this environment must be practical, timely and useful to those managing risk on the ground. They will be able to turn information into clear protective security insight, support busy operational teams, communicate professionally and maintain high standards of confidentiality.
This role would suit someone who understands both analysis and operational security, and who can help clients feel safe without unnecessary visibility or disruption.
About Prevail Partners
Prevail Partners delivers strategic advice, intelligence, specialist capabilities, and managed services to clients ranging from governments and multinational corporations to non-governmental organisations. Our services span Europe, the Middle East, and Africa.
We are united by a shared mission: to deliver Unrelenting Excellence in everything we do. That means operating with integrity, curiosity, accountability, and care.
What We Offer
At Prevail, we believe in recognising and rewarding our people. Our benefits are designed to support your wellbeing, development, and life beyond work:
Wholly owned subsidiary of Eli Lilly and Company
At Prevail Therapeutics, we are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders. Our mission is to translate recent advances in human genetics and gene therapy technology into medicines that slow or stop the neurodegenerative process. Our programs utilize a precision medicine approach targeting patient populations with urgent unmet needs, where there are currently no available therapies that modify the progressive course of their disorders. Prevail was formed in 2017 and we are building a team of dedicated, creative and talented individuals who share our passion for serving patients with neurodegenerative diseases. We pride ourselves on following great science, and we value collaboration, integrity and agility. We are based in the Alexandria Center for Life Science in New York City. Prevail Therapeutics was acquired by Eli Lilly and Company in January of 2021, and is now a wholly owned subsidiary of Eli Lilly. For information please visit the www.lilly.com website.
Offices: 430 E 29th St, New York, 10016, US
Wholly owned subsidiary of Eli Lilly and Company
At Prevail Therapeutics, we are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders. Our mission is to translate recent advances in human genetics and gene therapy technology into medicines that slow or stop the neurodegenerative process. Our programs utilize a precision medicine approach targeting patient populations with urgent unmet needs, where there are currently no available therapies that modify the progressive course of their disorders. Prevail was formed in 2017 and we are building a team of dedicated, creative and talented individuals who share our passion for serving patients with neurodegenerative diseases. We pride ourselves on following great science, and we value collaboration, integrity and agility. We are based in the Alexandria Center for Life Science in New York City. Prevail Therapeutics was acquired by Eli Lilly and Company in January of 2021, and is now a wholly owned subsidiary of Eli Lilly. For information please visit the www.lilly.com website.
Offices: 430 E 29th St, New York, 10016, US
